Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > ICO on Verge of Attracting Big Pharma Dollars

<< Previous

Bullboard Posts

Next >>

Comment by juansitoon Jun 09, 2020 12:20am

248 Views

Post# 31127304

RE:RE:ICO on Verge of Attracting Big Pharma Dollars

I made more money on ry bmo hexo tgod weed ac in last month than with Ico from 2014. And I think I made 40k out of this Penny...but gl hope Ico get back to 14c soon. Sold at 5c 4.5c. I had only 1 million shares in play and breakout did happen once...but second did not. I presume is coming June or July. Maybe I get a small position again at 4.5 if market allow me. GLTA

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China